Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Average (2020 - 2025)

Biofrontera (BFRI) has 6 years of Equity Average data on record, last reported at -$3.6 million in Q3 2025.

  • For Q3 2025, Equity Average fell 144.09% year-over-year to -$3.6 million; the TTM value through Sep 2025 reached -$3.6 million, down 144.09%, while the annual FY2024 figure was $4.6 million, 67.82% down from the prior year.
  • Equity Average reached -$3.6 million in Q3 2025 per BFRI's latest filing, down from -$2.1 million in the prior quarter.
  • Across five years, Equity Average topped out at $23.2 million in Q4 2022 and bottomed at -$9.4 million in Q3 2021.
  • Average Equity Average over 5 years is $6.2 million, with a median of $4.1 million recorded in 2021.
  • Peak YoY movement for Equity Average: skyrocketed 3641.79% in 2022, then tumbled 175.85% in 2025.
  • A 5-year view of Equity Average shows it stood at -$3.0 million in 2021, then soared by 869.17% to $23.2 million in 2022, then crashed by 87.45% to $2.9 million in 2023, then surged by 70.86% to $5.0 million in 2024, then plummeted by 172.76% to -$3.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Average were -$3.6 million in Q3 2025, -$2.1 million in Q2 2025, and $2.5 million in Q1 2025.